California Attorney General Rob Bonta on Thursday sued the six major companies that dominate the U.S. insulin market, ratcheting up the state’s assault on a profitable industry for artificially jacking up prices and making the indispensable drug less accessible for diabetes patients. The 47-page civil complaint alleges three pharmaceutical companies that control the insulin market — Eli Lilly and…
